Patrick Girondi says that a conflict of interest is causing Memorial Sloan Kettering Cancer Center to dawdle in developing a gene therapy that could potentially cure his son’s blood disease.
Lawsuit Accuses Sloan Kettering of Delaying Gene Therapy for Rare Blood Disease
